[The investigation of malignant hyperthermia susceptibility].

The European Malignant Hyperthermia Group has published updated guidelines for the investigation of malignant hyper-thermia (MH) susceptibility. This article gives a short description of the investigation of MH susceptibility in Denmark and an introduction to the new guidelines in Danish.

[Malignant hyperthermia].

Malignant hyperthermia susceptibility is a rare pharmacogenetic muscular disorder that may lead to potentially fatal complications in routine anesthesia. Malignant hyperthermia is triggered by volatile anesthetics and succinylcholine. In this article the pathophysiology of malignant hyperthermia, its signs, symptoms and treatment as well as safe anesthetic agents for individuals susceptible to malignant hyperthermia are discussed.